In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster session 6: Echocardiography: Valve Disease
Session

Event : EuroEcho 2018

Topic : Imaging - Other

  • Session type : Poster Session
  • Date : 08 December 2018
  • Time : 09:30 - 13:30

15 presentations in this session

Can mitral annular calcification (MAC) cause systolic anterior motion (SAM) of the mitral valve?

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : G Pressman (Philadelphia,US)

Discriminating severity in aortic stenosis: are left atrial mechanics the right tool?

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : P Alves (Coimbra,PT)

Left atrial strain correlates with cardiovascular events in patients with rheumatic mitral stenosi

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : F Castro (Guimaraes,PT)

The long term prognostic impact of mitral regurgitation in STEMI patients treated with primary PCI.

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : J Alves Guimaraes (Braga,PT)

Comparison of echocardiographic variables in severe degenerative and rheumatic mitral stenosis

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : G Pressman (Philadelphia,US)

Quadricuspid and bicuspid aortic valves: similarities and differences

Event : EuroEcho 2018

  • Session : Echocardiography: Valve Disease
  • Speaker : D Sharif (Haifa,IL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are